| |
|
|
|
|
|
|
|||
|
DE Hogge, JD Cashman, RK Humphries and CJ Eaves
Terry Fox Laboratory, British Columbia Cancer Agency, Department of
Medicine, University of British Columbia, Vancouver, Canada.
The ability of granulocyte-macrophage colony-stimulating factor (GM- CSF)
and G-CSF to influence hematopoiesis in long-term cultures (LTC) of human
marrow was studied by cocultivating light density normal human marrow cells
with human marrow fibroblast feeders engineered by retroviral infection to
constitutively produce one of these growth factors. Feeders producing
stable levels of 4 ng/mL GM-CSF or 20 ng/mL G-CSF doubled the output of
mature nonadherent cells. The numbers of both colony forming unit-GM
(CFU-GM) and erythroid burst forming unit (BFU-E) in the G-CSF LTC were
also increased (twofold and fourfold, respectively, after 5 weeks in
culture), but this effect was not seen with the GM-CSF feeders. At the time
of the weekly half medium change 3H-thymidine suicide assays showed
primitive adherent layer progenitors in LTC to be quiescent in both the
control and GM-CSF cultures. In contrast, in the G-CSF cultures, a high
proportion of primitive progenitors were in S-phase. A single addition of
either recombinant GM- CSF or G-CSF to LTC in doses as high as 80 ng/mL and
150 ng/mL, respectively, failed to induce primitive progenitor cycling.
However, three sequential daily additions of 150 ng/mL G-CSF did stimulate
primitive progenitors to enter S-phase and a single addition of 5 or 12.5
ng/mL of G-CSF together with 10 ng/mL GM-CSF was able to elicit the same
effect. Thus, selective elevation of G-CSF in human LTC stimulates
proliferation of primitive clonogenic progenitors, which may then proceed
through to the terminal stages of granulopoiesis. In contrast, the effects
of GM-CSF in this system appear limited to terminally differentiating
granulopoietic cells. However, when both GM- CSF and G-CSF are provided
together, otherwise biologically inactive doses show strong stimulatory
activity. These findings suggest that the production of both of these
growth factors by normal stromal cells may contribute to the support and
proliferation of hematopoietic cells, not only in LTC, but also in the
microenvironment of the marrow in vivo.
This article has been cited by other articles:
| |||||||||||
| Copyright © 1991 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||